ChromoCure, Inc. (KKUR) は上場企業です ヘルスケア セクターの Medical - Specialties 業界で事業展開. 本社所在地は Reno, アメリカ.
KKUR を有する IPO日 2005-04-27, 4 名の正社員, に上場 Other OTC, 時価総額 $8.2K.
ChromoCure, Inc. develops and provides proprietary cancer detection systems. The company offers Chromosomal Scanner Series 200, a cancer detection system to measure the genomic characteristic found in 100% of all cancers and never found in normal cells. It also applies its science and technology to non-toxic and non-invasive approaches to cancer therapy and cure research. The company was formerly known as Cyberhand Technologies International, Inc. and changed its name to ChromoCure, Inc. in June 2009. ChromoCure, Inc. was incorporated in 2001 and is based in Reno, Nevada.
